PPARA and metabolic dysfunction-associated steatotic liver disease: Given PPARα’s roles in lipid metabolism, inflammation, and metabolic regulation, it presents a promising therapeutic target for treating metabolic disorders such as hyperlipidemia, MASLD, and CVDs.